• Clinical Services
  • For Patients
  • For Visitors
  • Medical Professionals
  • Hospitals & Locations
  • Our Story
  • Find a Career
  • Find a Physician
  • My Account
  • Make a Payment
Skip Navigation

Cardiology Research Studies

Providence Hospital and Medical Centers is involved in several pharmaceutical and device sponsored clinical research studies. We continue to expand our interest in various areas of cardiology and research.

Contact Us

For more information regarding Cardiology studies please call the Research Department at Providence Hospital (248) 849-5805.

Jean Kelly, RN, BSN, CCRP jean.kelly@stjohn.org

Kathryn Telck, RN, BSN kathryn.telck@stjohn.org

Wissedi Njoh, RN, MSN, CCRP wissedi.njoh@stjohn.org

 

Congestive Heart Failure Studies

HF-ACTION

The purpose of this research study is to see if a long-term exercise program affects illness and survival in patients with congestive heart failure.  This study is being sponsored by a grant from the National Institutes of Health (NIH) at many centers across the United States and under the direction of Jeffrey Zaks, M.D. at Providence Hospital.

To be eligible for this study, one must:

  • be at least 18 years of age
  • have a diagnosis of congestive heart failure (CHF)
  • be receiving optimal medical therapy for CHF

There are certain conditions that one may have which will prevent one from participating in the study. 

Participation in this study may last as long as 4 years.

Acute Coronary Syndromes Studies

Early ACS

Acute coronary syndrome is a serious heart problem where the heart does not get enough oxygen.  This may be caused by partial blockage of one or more of the blood vessels in the heart and usually causes chest pain.  The medication eptifabide has been studied in over 17,000 patients and has been approved by the U.S. Food and Drug Administration for the treatment of acute coronary syndrome. It is used in conjuction with other anti-clotting medications to prevent blood clots from forming and further blocking the blood vessels in the heart. However, it is not approved by the FDA for early treatment of acute coronary syndrome.  The purpose of this research study is examine the safety and effectiveness of eptifibatide when given early to patients with acute coronary syndrome.

This study is sponsored by Millennium Pharmaceuticals, under the direction of Marcel Zughaib, M.D. at Providence Hospital.

To be eligible for this study, one must:

  • be at least 18 years of age
  • have at least 10 minutes of chest pain
  • have signs of acute coronary syndrome, such as EKG changes and blood enzyme elevation

There are certain conditions that one may have which will prevent one from participating in the study. 

Participation in this study lasts 1 year.

Carotid Stent Study

CAPTURE2

This study is being done to collect more information on the safety and effectiveness of the ACCULINKä Carotid Stent and ACCUNET devices after FDA approval/clearance of the devices used to treat a narrowed carotid artery.  The ACCULINKä Carotid Stent is an elastic-like metal tube that is used to hold open a narrow part of the artery.  Before the doctor places the stent, he will use a device called the ACCUNET Embolic Protection System.  This is a wire mesh basket that is designed to catch material (blood clots, fatty material) that could break off from the narrowed artery during the stent procedure.

The sponsor of this research study is Guidant Corporation, under the direction of Jamal Zarghami, M.D. and Marcel Zughaib, M.D. at Providence Hospital.

To be included in this study, one must:

  • have a ACCULINKä Carotid Stent placed by the study doctor

There are certain conditions that one may have which will prevent one from participating in the study. 

Participation in this study lasts 30 days.

 


 

Find a Physician